Professor Pietro Lampertico is Full Professor in the Gastroenterology, Director of the Gastroenterology and Hepatology Division, Head of the “A. M. e A. Migliavacca” Center for Liver Disease at the Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
A 1986 graduate of the State University of Milan with degrees in medicine and surgery, Professor Lampertico completed his postdoctoral research in the Department of Experimental Pathology at Tulane University in New Orleans, USA. Upon his return to Milan, he completed specialisations in liver diseases and internal medicine. He received his PhD in clinical methodology from the University of Milan in 1998. In the Gastroenterology Unit, Professor Lampertico is primarily involved in the clinical management of chronic viral hepatitis outpatients, particularly those with CHB and CHD. His research interests include the treatment of patients with chronic hepatitis/cirrhosis due to HBV and HDV, the long-term outcome of cirrhotic patients undergoing antiviral treatment, and the diagnosis and management of antiviral resistance to oral nucleos(t)ide analogues. Since November 2016, as Director of the Gastroenterology and Hepatology Division, he overlooks all the medical and scientific activities in the field of liver disease.
Professor Lampertico is currently a reviewer for several top-ranked international journals. He is a member of AASLD, EASL and AISF and serves in the Editorial Board of prestigious journals.
He has spoken internationally about liver disease, specifically the natural history of HBV and antiviral treatment of HBV and HDV, and has published several articles and book chapters. He is currently involved in national and international HBV and HDV clinical trials.